IAPP boosts islet macrophage IL-1 in type 2 diabetes

被引:30
|
作者
Mandrup-Poulsen, Thomas [1 ,2 ,3 ]
机构
[1] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark
[2] Hagedorn Res Inst, Gentofte, Denmark
[3] Karolinska Inst, Dept Med & Surg, Stockholm, Sweden
关键词
OXIDATIVE STRESS; INTERLEUKIN-1; ACTIVATION; MELLITUS; PROTEIN;
D O I
10.1038/ni1010-881
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IAPP, a hormone secreted together with insulin and deposited in pancreatic islets in type 2 diabetes, can induce macrophage processing of interleukin 1 linked to beta-cell destruction in type 2 diabetes.
引用
收藏
页码:881 / 883
页数:4
相关论文
共 50 条
  • [31] PC12 cells express IL-1 receptor type I and response to IL-1β stimulation
    Shu, Hai-Fen
    Wang, Bai-Ren
    Bi, Hui
    Pei, Jian-Ming
    Wang, Xi
    Fan, Juan
    Ju, Gong
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2007, 157 (2-3) : 187 - 195
  • [32] Signaling Through Purinergic Receptor P2Y2Enhances Macrophage IL-1β Production
    de la Rosa, Gonzalo
    Gomez, Ana I.
    Banos, Maria C.
    Pelegrin, Pablo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 17
  • [33] Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes
    Marc Y. Donath
    Joachim Størling
    Kathrin Maedler
    Thomas Mandrup-Poulsen
    Journal of Molecular Medicine, 2003, 81 : 455 - 470
  • [34] IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
    Peiro, Concepcion
    Lorenzo, Oscar
    Carraro, Raffaele
    Sanchez-Ferrer, Carlos F.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [35] IL-1 Receptor Accessory Protein-Ig/IL-1 Receptor Type II-Ig Heterodimer Inhibits IL-1 Response More Strongly than Other IL-1 Blocking Biopharmaceutical Agents
    Hanawa, Haruo
    Ota, Yoshimi
    Ding, Limin
    Chang, He
    Yoshida, Kaori
    Otaki, Keita
    Hao, Kazuhisa
    Kasahara, Sou
    Kodama, Makoto
    Nakazawa, Mikio
    Aizawa, Yoshifusa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (03) : 455 - 464
  • [36] Analysis of islet inflammation in human type 1 diabetes
    Willcox, A.
    Richardson, S. J.
    Bone, A. J.
    Foulis, A. K.
    Morgan, N. G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 155 (02) : 173 - 181
  • [37] IL-1 at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?
    Giacomelli, Roberto
    Ruscitti, Piero
    Alvaro, Saverio
    Ciccia, Francesco
    Liakouli, Vasiliki
    Di Benedetto, Paola
    Guggino, Giuliana
    Berardicurti, Onorina
    Carubbi, Francesco
    Triolo, Giovanni
    Cipriani, Paola
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (08) : 849 - 855
  • [38] Are selected IL-1 polymorphisms and selected subgingival microorganisms significantly associated to periodontitis in type 2 diabetes patients? a clinical study
    Deppe, Herbert
    Muecke, Thomas
    Wagenpfeil, Stefan
    Kesting, Marco
    Karl, Julia
    Noe, Sebastian
    Sculean, Anton
    BMC ORAL HEALTH, 2015, 15
  • [39] Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1
    Orban, Tihamer
    Sosenko, Jay M.
    Cuthbertson, David
    Krischer, Jeffrey P.
    Skyler, Jay S.
    Jackson, Richard
    Yu, Liping
    Palmer, Jerry P.
    Schatz, Desmond
    Eisenbarth, George
    DIABETES CARE, 2009, 32 (12) : 2269 - 2274
  • [40] TLR4-Upregulated IL-1β and IL-1RI Promote Alveolar Macrophage Pyroptosis and Lung Inflammation through an Autocrine Mechanism
    He, Xingying
    Qian, Yongbing
    Li, Zhigang
    Fan, Erica K.
    Li, Yuehua
    Wu, Liang
    Billiar, Timothy R.
    Wilson, Mark A.
    Shi, Xueyin
    Fan, Jie
    SCIENTIFIC REPORTS, 2016, 6